SWOG S1416

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Metastatic

Status:

Closed

Phase II Randomized Placebo-Controlled Trial of Cisplatin with or Without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer

NCT#02595905

Effective, today, June 15th, 2019, SWOG S1416, is permanently closed to accrual.